2010Seminars in Cardiothoracic and Vascular AnesthesiaRequires access

Heparin-Induced Thrombocytopenia

Joseph W. Szokol

Open publisher page 13 citations

Abstract

Heparin-induced thrombocytopenia (HIT) is an antibody-mediated reaction caused by exposure to heparin that can lead to devastating thrombotic complications. HIT usually occurs 5 to 10 days after exposure to heparin but can happen more rapidly to patients who are reexposed to heparin within 100 days. The hallmark of this disorder is a sudden drop in platelet count of greater than 50%. Once HIT is suspected the heparin must be immediately discontinued and an anticoagulant (direct thrombin inhibitor or heparinoid) started. For patients presenting for cardiac surgery and cardiopulmonary bypass that have a history of HIT and positive antibodies a direct thrombin inhibitor such as lepirudin, argatroban or bivalirudin must be used in lieu of heparin.

About this research paper

What this paper is about

Heparin-induced thrombocytopenia (HIT) is an antibody-mediated reaction caused by exposure to heparin that can lead to devastating thrombotic complications. HIT usually occurs 5 to 10 days after exposure to heparin but can happen more rapidly to patients who are reexposed to heparin within 100 days. The hallmark of this disorder is a sudden drop in platelet count of greater than 50%. Once HIT is suspected the heparin must be immediately discontinued and an anticoagulant (direct thrombin inhibitor or heparinoid) started. For patients presenting for cardiac surgery and cardiopulmonary bypass that have a history of HIT and positive antibodies a direct thrombin inhibitor such as lepirudin, argatroban or bivalirudin must be used in lieu of heparin.

Why it matters

OpenAlex reports 13 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Heparin-induced thrombocytopenia (HIT) is an antibody-mediated reaction caused by exposure to heparin that can lead to devastating thrombotic complications. HIT usually occurs 5 to 10 days after exposure to heparin but can happen more rapidly to patients who are reexposed to heparin within 100 days. The hallmark of this disorder is a sudden drop in platelet count of greater than 50%. Once HIT is suspected the heparin must be immediately discontinued and an anticoagulant (direct thrombin inhibitor or heparinoid) started. For patients presenting for cardiac surgery and cardiopulmonary bypass that have a history of HIT and positive antibodies a direct thrombin inhibitor such as lepirudin, argatroban or bivalirudin must be used in lieu of heparin.

Key concepts: Argatroban, Lepirudin, Heparin-induced thrombocytopenia, Medicine, Bivalirudin, Heparin, Hirudin, Discovery and development of direct thrombin inhibitors

Related papers

Back to paper searchBrowse research topicsOriginal source
Heparin-Induced Thrombocytopenia — Research Paper | ScholarLens